On-Demand - TSANZ Webinar Series: PACT CRE -Accelerating translational research to find cure for IPF: Can we REMAP-ILD?

Event Details

This on-demand webinar will educate health professionals about a Randomised, Embedded, Multifactorial, Adaptive, Platform (REMAP) trial design for interstitial lung disease (ILD). Tune in to learn from an international expert about this project with the potential to change the landscape of clinical trials and the lives of people living with pulmonary fibrosis. 

Title: Accelerating translational research to find cure for IPF: Can we REMAP-ILD?

Chair: Prof Tamera Corte

Presenter: Prof Gisli Jenkins

Professor Gisli Jenkins is an NIHR Research Professor and is Head of the Margaret Turner-Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute. Prof Jenkins' research focuses on Interstitial Lung Diseases, and Pulmonary Fibrosis in particular. His team works to understand the biological basis for the development of pulmonary fibrosis and aims to translate this understanding in to improved outcomes for patients. He is the Principal Investigator of a number of longitudinal observational studies including the PROFILE study, the INJUSTIS Study, the UKILD Post COVID ILD study as well as the DEMISTIFI Multi-Morbidity consortium. Prof Jenkins was awarded the ERS Gold Medal in Interstitial Lung Disease in 2020. In 2022 he became a Fellow of the European Respiratory Society, and appointed President of Action for Pulmonary Fibrosis.  


Pricing Details